These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 9244692

  • 21. Effects of calcium channel blockers on experimental glomerular injury.
    Dworkin LD.
    J Am Soc Nephrol; 1990 Sep; 1(3 Suppl 1):S21-7. PubMed ID: 16989074
    [Abstract] [Full Text] [Related]

  • 22. Acute and long-term effects of ACE inhibition on renal haemodynamics in glomerular and interstitial nephropathies.
    Guidi E, Minetti EE, Cozzi MG.
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):40-5. PubMed ID: 11984747
    [Abstract] [Full Text] [Related]

  • 23. What is the optimal blood pressure target in renal patients?
    Ruilope LM, Campo C, Segura J, Rodicio JL.
    Adv Nephrol Necker Hosp; 2001 Mar; 31():43-53. PubMed ID: 11692470
    [Abstract] [Full Text] [Related]

  • 24. Increased vascular alpha1-adrenergic sensitivity in patients with renal failure: receiving recombinant erythropoeitin.
    Abiose AK, Aronow WS, Moreno H, Nair CK, Blaschke TF, Hoffman BB.
    Am J Ther; 2007 Mar; 14(5):427-34. PubMed ID: 17890929
    [Abstract] [Full Text] [Related]

  • 25. The interrelationships among filtration surface area, blood pressure, and chronic renal disease.
    Brenner BM, Anderson S.
    J Cardiovasc Pharmacol; 1992 Mar; 19 Suppl 6():S1-7. PubMed ID: 1382155
    [Abstract] [Full Text] [Related]

  • 26. Progressive renal disease: a disorder of adaptation.
    Anderson S, Brenner BM.
    Q J Med; 1989 Mar; 70(263):185-9. PubMed ID: 2690171
    [No Abstract] [Full Text] [Related]

  • 27. Should beta-blockers be used to control hypertension in people with chronic kidney disease?
    Hart PD, Bakris GL.
    Semin Nephrol; 2007 Sep; 27(5):555-64. PubMed ID: 17868793
    [Abstract] [Full Text] [Related]

  • 28. Mechanisms of progression of chronic renal damage.
    Klahr S.
    J Nephrol; 1999 Sep; 12 Suppl 2():S53-62. PubMed ID: 10688403
    [Abstract] [Full Text] [Related]

  • 29. [Vascular mechanisms of renal fibrosis. Vasculonephropathies and arterial hypertension].
    Meyrier A.
    Bull Acad Natl Med; 1999 Sep; 183(1):33-45; discussion 45-6. PubMed ID: 10371763
    [Abstract] [Full Text] [Related]

  • 30. [Antipressor and vasodilator substances of the kidney (review of foreign literature)].
    Markov KhM.
    Urol Nefrol (Mosk); 1969 Sep; 34(4):61-5. PubMed ID: 4904821
    [No Abstract] [Full Text] [Related]

  • 31. Renal vascular changes in chronic renal insufficiency.
    Gömöri P, Munkácsi I, Varga I, Zolnai B, Szalay E.
    Acta Morphol Acad Sci Hung; 1968 Sep; 16(3):353-62. PubMed ID: 5716973
    [No Abstract] [Full Text] [Related]

  • 32. Angiotensin II increases intrarenal transforming growth factor-beta1 in rats submitted to sodium overload independently of blood pressure.
    Rosón MI, Cao G, Della Penna S, Gorzalczany S, Pandolfo M, Toblli JE, Fernández BE.
    Hypertens Res; 2008 Apr; 31(4):707-15. PubMed ID: 18633183
    [Abstract] [Full Text] [Related]

  • 33. Mild chronic renal insufficiency induces sympathetic overactivity.
    Tinucci T, Abrahão SB, Santello JL, Mion D.
    J Hum Hypertens; 2001 Jun; 15(6):401-6. PubMed ID: 11439315
    [Abstract] [Full Text] [Related]

  • 34. Humoral regulation of glomerular pressure in the toad kidney.
    Uranga J.
    Acta Physiol Lat Am; 1967 Jun; 17(1):95-101. PubMed ID: 6055050
    [No Abstract] [Full Text] [Related]

  • 35. Long-term decline in renal function is linked to initial pulse pressure in the essential hypertensive.
    Gosse P, Coulon P, Papaioannou G, Litalien J, Lemetayer P.
    J Hypertens; 2009 Jun; 27(6):1303-8. PubMed ID: 19307982
    [Abstract] [Full Text] [Related]

  • 36. [Concept and definition of chronic kidney failure and uremia].
    Kusunoki N, Maseki T.
    Nihon Rinsho; 1968 Oct; 26(10):2250-8. PubMed ID: 4886439
    [No Abstract] [Full Text] [Related]

  • 37. [Surgical treatment pf vasorenal hypertension complicated by renal failure].
    Dzhavad-Zade MD, Figarov IG.
    Urologiia; 2000 Oct; (3):3-5. PubMed ID: 11186706
    [Abstract] [Full Text] [Related]

  • 38. Systemic hypertension and nondiabetic chronic kidney disease: the best evidence-based therapeutic approach today.
    Jafar TH.
    Eur Rev Med Pharmacol Sci; 2005 Oct; 9(1):1-12. PubMed ID: 15850139
    [Abstract] [Full Text] [Related]

  • 39. Role of increased glomerular protein traffic in the progression of renal failure.
    Bruzzi I, Benigni A, Remuzzi G.
    Kidney Int Suppl; 1997 Nov; 62():S29-31. PubMed ID: 9350674
    [Abstract] [Full Text] [Related]

  • 40. The anesthetic management of a child with chronic hypotension for renal transplantation.
    Kim TW, Bailard N, Coveler LA.
    J Clin Anesth; 2006 Jun; 18(4):297-9. PubMed ID: 16797433
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.